Extension Study of Tocilizumab Long Term Treatment of Moderate to Severe Rheumatoid Arthritis Patients
Clinical trial NCT01347983 · COMPLETED
Trial details
- NCT number
- NCT01347983
- Sponsor
- Chugai Pharma Taiwan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2013-03-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.